Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry programMing‐Ying Lu, Hsing‐Tao Kuo, Kuo‐Chih Tseng et al.|Clinical and Molecular Hepatology|2023Cited by 26
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE studyChen-Hua Liu, Jia‐Horng Kao, Ming‐Lung Yu et al.|Journal of the Formosan Medical Association|2018Cited by 10
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected PatientsChi-Chieh Yang, Ming‐Lung Yu, Wei-Lun Tsai et al.|PLoS ONE|2015Cited by 9